Want to see HK:1501 full AI Analyst Report?
1501 Stock Chart & Stats
HK$29.30
HK$0.10(0.37%)
At close: 4:00 PM EST
HK$29.30
HK$0.10(0.37%)
Day’s Range― - ―
52-Week RangeHK$27.86 - HK$41.40
Previous CloseN/A
Volume37.20K
Average Volume (3M)162.52K
Market Cap
HK$6.34B
Enterprise ValueHK$5.57B
Total Cash (Recent Filing)HK$1.32B
Total Debt (Recent Filing)HK$716.25M
Price to Earnings (P/E)21.6
Beta-0.02
Next Earnings
Mar 22, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.87%
Share Statistics
EPS (TTM)1.18
Shares Outstanding211,200,000
10 Day Avg. Volume152,760
30 Day Avg. Volume162,520
Financial Highlights & Ratios
PEG Ratio1.13
Price to Book (P/B)2.32
Price to Sales (P/S)4.35
P/FCF Ratio16.67
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.39
Revenue Forecast (FY)HK$1.23B
Bulls Say, Bears Say
Bulls Say
Steady Revenue GrowthSteady revenue growth, including 12.7% in 2025, indicates continued expansion in demand for the company’s medical-device offerings. A growing revenue base can support operating scale, product investment, and broader provider penetration over the next several quarters.
Healthy ProfitabilityNet and EBIT margins around 20% show that the company retains meaningful operating profitability while expanding revenue. This earnings base can help fund research, commercialization, and strategic investment, although preserving margins will remain important as costs and pricing pressure evolve.
Improved Cash GenerationThe strong 2025 operating and free cash flow rebound improves the company’s ability to fund operations and investment internally. Free cash flow covering most of net income also suggests better earnings conversion in the latest period, supporting financial resilience over the medium term.
Bears Say
Higher LeverageThe sharp increase in debt has reduced financial flexibility and makes the business more sensitive to earnings volatility. Higher leverage can constrain future investment and capital allocation while increasing the importance of sustaining operating performance and cash generation.
Margin CompressionThe multi-year decline in net margin indicates that revenue growth has not translated into the same level of profitability as earlier periods. Continued cost increases or pricing pressure could limit earnings growth and reduce the company’s capacity to convert expansion into durable shareholder returns.
Volatile Free Cash FlowAlthough cash generation improved materially in 2025, prior negative free cash flow shows that earnings conversion has been inconsistent over time. Such volatility can complicate investment planning, debt management, and shareholder distributions, particularly if working capital or investment needs rise again.
Shanghai Kindly Medical Instruments Co., Ltd. Class H News
1501 FAQ
What was Shanghai Kindly Medical Instruments Co., Ltd. Class H’s price range in the past 12 months?
Shanghai Kindly Medical Instruments Co., Ltd. Class H lowest stock price was HK$27.86 and its highest was HK$41.40 in the past 12 months.
What is Shanghai Kindly Medical Instruments Co., Ltd. Class H’s market cap?
Shanghai Kindly Medical Instruments Co., Ltd. Class H’s market cap is HK$6.34B.
When is Shanghai Kindly Medical Instruments Co., Ltd. Class H’s upcoming earnings report date?
Shanghai Kindly Medical Instruments Co., Ltd. Class H’s upcoming earnings report date is Mar 22, 2027 which is in 141 days.
How were Shanghai Kindly Medical Instruments Co., Ltd. Class H’s earnings last quarter?
Shanghai Kindly Medical Instruments Co., Ltd. Class H released its earnings results on Aug 24, 2026. The company reported HK$0.631 earnings per share for the quarter.
Is Shanghai Kindly Medical Instruments Co., Ltd. Class H overvalued?
According to Wall Street analysts Shanghai Kindly Medical Instruments Co., Ltd. Class H’s price is currently Overvalued.
Does Shanghai Kindly Medical Instruments Co., Ltd. Class H pay dividends?
Shanghai Kindly Medical Instruments Co., Ltd. Class H pays a Notavailable dividend of HK$0.26 which represents an annual dividend yield of 0.87%. See more information on Shanghai Kindly Medical Instruments Co., Ltd. Class H dividends here
What is Shanghai Kindly Medical Instruments Co., Ltd. Class H’s EPS estimate?
Shanghai Kindly Medical Instruments Co., Ltd. Class H’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Shanghai Kindly Medical Instruments Co., Ltd. Class H have?
Shanghai Kindly Medical Instruments Co., Ltd. Class H has 211,200,000 shares outstanding.
What happened to Shanghai Kindly Medical Instruments Co., Ltd. Class H’s price movement after its last earnings report?
Shanghai Kindly Medical Instruments Co., Ltd. Class H reported an EPS of HK$0.631 in its last earnings report. Following the earnings report the stock price went up 0.707%.
Which hedge fund is a major shareholder of Shanghai Kindly Medical Instruments Co., Ltd. Class H?
Currently, no hedge funds are holding shares in HK:1501
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Shanghai Kindly Medical Instruments Co., Ltd. Class H Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.09%
12-Months-Change
Fundamentals
Return on Equity
9.64%
Trailing 12-Months
Asset Growth
42.09%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Shanghai Kindly Medical Instruments Co., Ltd. Class H
Shanghai Kindly Medical Instruments Co., Ltd., founded in 2006 and based in Shanghai, China, focuses on the research, development, production, and international sales of cardiovascular interventional medical devices. The company's products reach customers across Mainland China, Europe, the United States, and various other global regions. Its comprehensive range of interventional instruments includes guiding catheters, which facilitate the introduction of balloon catheters, guidewires, or other therapeutic tools; micro catheters, offering support for guidewire placement; and guidewires themselves, integral to percutaneous transluminal angioplasty (PTA) surgical procedures. The portfolio also features angiography catheters for injecting contrast media and fluids, along with Y-connector packs specifically designed for PTCA surgery. Further product offerings comprise inflation devices, essential for balloon inflation during vessel dilation or stent deployment; single-use manifolds and manifold kits; and pressure bandages utilized for compression hemostasis. The company additionally manufactures single-use angiography syringes, stopcocks for surgical pressure monitoring, sterile Seldinger needles for arterial puncture, introducer sets, single-use pressure transducers, extension tubes for pressure monitoring, and introducer tool kits employed in percutaneous vertebroplasty. Beyond these specialized tools, Shanghai Kindly Medical Instruments provides a variety of medical accessories, such as check valves, needle-free connectors, male Luer locks, bi-stoppers, Heparian caps, flush devices, and flow regulators. Its broader product selection covers items like joint intervention kits, disposable respirator masks, vaginal dilators (for examinations), Foley catheters, infusion pumps, disposable automatic umbilical cord clamps, single-use infusion connectors and accessories, and burette infusion sets (without needles). Serving medical device manufacturers and other clients, the company operates as a subsidiary of Shanghai Kindly Enterprise Development Group Co., Ltd.
Shanghai Kindly Medical Instruments Co., Ltd. Class H (1501) Earnings & Revenues
Technical Analysis
Shandong Weigao Group Medical Polymer Co
―
PW Medtech Group Ltd.
―
Modern Dental Group Limited
―
Angelalign Technology Inc.
―
OrbusNeich Medical Group Holdings Limited
―








